FM-101 (Future Medicine)

N/A

Report date: 2025/05/29 16:54:23
NME

Base Information

Drug NameFM-101 (Future Medicine)
Drug Alias NameFM 101 - Future MedicineLJ-2698
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A3 receptor antagonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsOcular HypertensionMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandNetherlandsHungary +[5] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFuture Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University
Inactive CompaniesFuture Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsOcular HypertensionMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A